Authors
Latest:
Study Insights: Patient Engagement in Drug DevelopmentInitial findings from a DIA study of patient-centric initiatives in drug development reveal pharma’s desire to move toward true patient-centricity, but approaches to implementation are varied.
Latest:
Mobile Research Nursing - Bringing the Trial to the PatientThe ability to carry out clinical trial visits in a patient’s home, workplace or location of choice is still an uncommon concept. However, mobile trained research nurses can expand on this idea by conducting ‘off-site’ study visits.
Latest:
New Clinical Trials Law in France: Advantages for Medical Device StudiesThe new law on research in France introduces changes for the medical device industry by facilitating the conduct of postmarketing studies. Devices will no longer have to be provided free of charge for low-risk interventional studies making France a possible location for such trials in the future.
Latest:
Mobile Research Nursing - Bringing the Trial to the PatientThe ability to carry out clinical trial visits in a patient’s home, workplace or location of choice is still an uncommon concept. However, mobile trained research nurses can expand on this idea by conducting ‘off-site’ study visits.
Latest:
Creating Medicines ‘Appropriate for All’Bristol-Myers Squibb’s cardiovascular development leader discusses the importance of diversifying clinical trials for better patient outcomes.
Latest:
Point of View: Traceability and Transparency Should be Mandatory for All Human BiospecimensTransparency regarding the source of biospecimens would improve research quality, reproducibility, and translational use of acquired knowledge. Scientific robust publications, dissemination and communication are central to this-as are the regulatory reporting guidelines in play.
Latest:
Point of View: Traceability and Transparency Should be Mandatory for All Human BiospecimensTransparency regarding the source of biospecimens would improve research quality, reproducibility, and translational use of acquired knowledge. Scientific robust publications, dissemination and communication are central to this-as are the regulatory reporting guidelines in play.
Latest:
Point of View: Traceability and Transparency Should be Mandatory for All Human BiospecimensTransparency regarding the source of biospecimens would improve research quality, reproducibility, and translational use of acquired knowledge. Scientific robust publications, dissemination and communication are central to this-as are the regulatory reporting guidelines in play.
Latest:
Point of View: Traceability and Transparency Should be Mandatory for All Human BiospecimensTransparency regarding the source of biospecimens would improve research quality, reproducibility, and translational use of acquired knowledge. Scientific robust publications, dissemination and communication are central to this-as are the regulatory reporting guidelines in play.
Latest:
Point of View: Traceability and Transparency Should be Mandatory for All Human BiospecimensTransparency regarding the source of biospecimens would improve research quality, reproducibility, and translational use of acquired knowledge. Scientific robust publications, dissemination and communication are central to this-as are the regulatory reporting guidelines in play.
Latest:
Point of View: Traceability and Transparency Should be Mandatory for All Human BiospecimensTransparency regarding the source of biospecimens would improve research quality, reproducibility, and translational use of acquired knowledge. Scientific robust publications, dissemination and communication are central to this-as are the regulatory reporting guidelines in play.
Latest:
A Successful Study: The Principal Investigator’s PerspectiveDr. George Atiee shares his perspectives, from that of the principal investigator, on how stakeholders can execute a successful study.
Latest:
Mitigating Supply Chain Risk in Clinical TrialsOutlining a decision-making framework that integrates real-world signals with supply planning techniques to reduce risk and avoid potential interruptions.
Latest:
Mitigating Supply Chain Risk in Clinical TrialsOutlining a decision-making framework that integrates real-world signals with supply planning techniques to reduce risk and avoid potential interruptions.
Latest:
How to Pick the Right Drug Doses for Pregnant WomenThe majority of pregnant women are prescribed treatments that can include antibiotics, antivirals and more. However, little to no information is available about the appropriate dose to prescribe or the potential adverse fetal effects.
Latest:
How to Pick the Right Drug Doses for Pregnant WomenThe majority of pregnant women are prescribed treatments that can include antibiotics, antivirals and more. However, little to no information is available about the appropriate dose to prescribe or the potential adverse fetal effects.
Latest:
What's Behind the Clinical Innovation Gap?Though digital technology has improved the R&D process, when it comes to important clinical benefits and outcomes, modern biotech products have rarely shown the advantages of older generations of drugs.
Latest:
The Promise of Liquid Biopsy TechnologyThe ability to diagnose cancer at earlier stages of the disease is constrained by the specificity and mechanics of traditional diagnostic methods. The growing use of liquid biopsy technology may help overcome such barriers and potentially revolutionize cancer research, patient treatment, and survivor care.
Latest:
Mitigating Supply Chain Risk in Clinical TrialsOutlining a decision-making framework that integrates real-world signals with supply planning techniques to reduce risk and avoid potential interruptions.
Latest:
Can We Predict Drug Efficacy with Artificial Intelligence?Approaches such as machine learning, AI and neural networks are still in their infancy, but with AI companies rewriting the code for drug discovery, the implications in pharma are likely to be far ranging in the coming years.
Latest:
Consider an Enterprise Wide Project Management OfficeInterest in improved project management practices is growing in the fast-moving pharma industry.
Latest:
Investigative Site Placement Practices to Support Operation Warp SpeedComparing late-stage COVID-19 vaccine trials to historical practices.
Latest:
Bridging the Gap for Better Patient EngagementSurvey examines issues related to clinical trials quality and participation from the patients' view.
Latest:
SHARE-ing CDISC Standards Through a Cloud-based Metadata RepositoryCDISC executive talks about the creation of their cloud-based platform to free standards from PDF documents.
Latest:
The Missing Puzzle Piece of the Cloud Platform RevolutionAs clinical trials have become more complex and costly, traditional paper-based data management systems have increasingly proved impractical and ineffective. Cloud-based technologies fit the bill, and industry professionals have begun to recognize this reality and reap the benefits at an ever-increasing rate.
